EHMTI-0377. The influence of genetic constitution on migraine drug responses

by Christensen, AF, Esserlind, AL, Werge, T, Stefansson, H, Olesen, J
Published 2014

Dissociation of accumulated genetic risk and disease severity in patients with schizophrenia

by Papiol, S, Malzahn, D, Kästner, A, Sperling, S, Begemann, M, Stefansson, H, Bickeböller, H, Nave, K-A, Ehrenreich, H
Published 2011

EHMTI-0380. The association of migraine susceptibility loci with severe migraine characteristics in a clinic-based migraine sample

by Esserlind, A, Christensen, AF, Steinberg, S, Grarup, N, Pedersen, O, Hansen, T, Werge, T, Folkmann-Hansen, T, Husemoen, LL, Linneberg, A, Budtz-Jorgensen, E, Westergaard, M Lurenda, Stefansson, H, Olesen, J
Published 2014

De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia

by Kirov, G, Pocklington, A J, Holmans, P, Ivanov, D, Ikeda, M, Ruderfer, D, Moran, J, Chambert, K, Toncheva, D, Georgieva, L, Grozeva, D, Fjodorova, M, Wollerton, R, Rees, E, Nikolov, I, van de Lagemaat, L N, Bayés, À, Fernandez, E, Olason, P I, Böttcher, Y, Komiyama, N H, Collins, M O, Choudhary, J, Stefansson, K, Stefansson, H, Grant, S G N, Purcell, S, Sklar, P, O'Donovan, M C, Owen, M J
Published 2012

Genome-wide common and rare variant analysis provides novel insights into clozapine-associated neutropenia

by Legge, S E, Hamshere, M L, Ripke, S, Pardinas, A F, Goldstein, J I, Rees, E, Richards, A L, Leonenko, G, Jorskog, L F, Chambert, K D, Collier, D A, Genovese, G, Giegling, I, Holmans, P, Jonasdottir, A, Kirov, G, McCarroll, S A, MacCabe, J H, Mantripragada, K, Moran, J L, Neale, B M, Stefansson, H, Rujescu, D, Daly, M J, Sullivan, P F, Owen, M J, O'Donovan, M C, Walters, J T R
Published 2017